natgillin/translations-raw huggingface dataset:
The safety requirements in diagnostic laboratories working with AI viruses must cover both the containment of the viruses as a threat to animal health and the protection of those working in the laboratory (and those outside) from any zoonotic risk.
Varnostne zahteve v diagnostičnih laboratorijih, ki obravnavajo viruse aviarne influence, morajo vključevati obvladovanje virusov, ki so grožnja za zdravje živali, in zaščito ljudi, ki delajo v laboratoriju (in zunaj njega), pred zoonotskim tveganjem.
In the Community, the minimal safety requirements for laboratories are set out in the several Directives.
Minimalne varnostne zahteve za laboratorije v Skupnosti so določene v več direktivah.
In addition, operational aspects are described and set out in underlying European Norms (EN).
Razen tega so operativni vidiki opisani in določeni v temeljnih evropskih normah.
For the operation of laboratories for diagnostic purposes there are additional regulations (EN), such as good laboratory practice.
Za delovanje laboratorijev za diagnostične namene obstajajo dodatni predpisi (evropske norme), kot je dobra laboratorijska praksa.
Community directives on laboratories
Direktive Skupnosti o laboratorijih
Council Directive 89/391/EEC of 12 June 1989 on the introduction of measures to encourage improvements in the safety and health of workers at work (OJ L 183, 29.6.1989, p. 1).
Direktiva Sveta 89/391/EGS z dne 12. junija 1989 o uvajanju ukrepov za spodbujanje izboljšav varnosti in zdravja delavcev pri delu (UL L 183, 29.6.1989, str. 1).
Council Directive 90/679/EEC of 26 November 1990 on the protection of workers from risks related to exposure to biological agents at work (seventh individual Directive within the meaning of Article 16(1) of Directive 89/391/EEC) (OJ L 374, 31.12.1990, p. 1).
Direktiva Sveta 90/679/EGS z 26. novembra 1990 o varovanju delavcev pred tveganjem zaradi izpostavljenosti biološkim dejavnikom pri delu (sedma posebna direktiva v skladu s členom 16(1) Direktive 89/391/EGS) (UL L 374, 31.12.1990, str. 1).
If there is diagnostic done by Polymerase Chain Reaction (PCR) and cloning of PCR-products into a bacterial plasmid for propagation, for example, for the purpose of DNA-sequencing, the following Directive and European Norms (EN) apply in addition to those two Directives:
Če diagnoza poteka z verižno polimerizacijo (PCR) in kloniranjem produktov PCR v bakterijskem plazmidu za razmnoževanje, na primer za sekvenciranje DNK, poleg obeh direktiv veljajo naslednja direktiva in evropske norme:
Council Directive 90/219/EEC of 23 April 1990 on the contained use of genetically modified micro-organisms (OJ L 117, 8.5.1990, p. 1).
Direktiva Sveta 90/219/EGS z dne 23. aprila 1990 o uporabi gensko spremenjenih mikroorganizmov v zaprtih sistemih (UL L 117, 8.5.1990, str. 1).
In addition to the Community Directives, European Norms (EN) must be recognised:
Razen direktiv Skupnosti je treba upoštevati evropske norme (EN):
EN 12128 Biotechnology.
EN 12728 Biotehnologija.
Laboratories for research, development and analysis.
Raziskovalni, razvojni in analitski laboratoriji.
Containment levels of microbiology laboratories, areas of risk, localities and physical safety requirements
Zadrževalne stopnje v mikrobioloških laboratorijih, področja tveganja, prostori in fizikalne varnostne zahteve.
EN 12738 Biotechnology.
EN 12738 Biotehnologija.
Guidance for containment of animals inoculated with micro-organisms in experiments
Navodilo za zadrževanje poskusnih živali, cepljenih z mikroorganizmi.
EN 12740 Biotechnology.
EN 12740 Biotehnologija.
Guidance for handling, inactivating and testing of waste
Navodilo za ravnanje z odpadki, njihovo inaktivacijo in preskušanje.
EN 12741 Biotechnology.
EN 12741 Biotehnologija.
Guidance for biotechnology laboratory operations
Navodilo za delovanje biotehnoloških laboratorijev.
For operating/managing a laboratory, the following conditions apply:
Za delovanje/upravljanje laboratorija veljajo naslednji pogoji:
Requirements for Laboratories (containment levels 1 to 4)
Zahteve za laboratorije (stopnje zadrževanja 1 do 4)
In accordance with Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (seventh individual Directive within the meaning of Article 16(1) of Directive 89/391/EEC) (OJ L 262, 17.10.2000, p. 21), Directive 90/219/EEC and European Norms: EN 12128; EN 12740; EN 12741.
V skladu z Direktivo 2000/54/ES Evropskega parlamenta in Sveta z dne 18. septembra 2000 o varstvu delavcev pred tveganji zaradi izpostavljenosti biološkim dejavnikom pri delu (sedma posebna direktiva v smislu člena 16(1) Direktive 89/391/EGS) (UL L 262, 17.10.2000, str. 21), Direktivo Sveta 90/219/EGS in evropskimi normami: EN 12128; EN 12740; EN 12741.
Containment measures
Zadrževalni ukrepi
Containment level
Stopnja zadrževanja
Laboratory suite: isolation
Laboratorijski oddelek: izolacija
Laboratories separated by doors
Laboratoriji, ločeni z vrati
An observation window or alternative must be present so that occupants can be seen
Prisotno mora biti opazovalno okno ali nadomestna možnost, ki omogoča opazovanje ljudi
optional
neobvezno
Hand washing facilities must be provided for personnel
Zagotovljeni morajo biti prostori, v katerem si osebje umiva roke
Disinfecting facilities (hands) must be provided
Zagotovljeni morajo biti prostori za dezinfekcijo (roke)
Restricted access
Omejen dostop
Specific measures to control aerosol
Posebni ukrepi za nadzor razširjanja aerosolov
minimise
čim bolj zmanjšati
prevent
preprečiti
Biohazard sign on the door
Znaki za biološko nevarnost na vratih
Shower
Prha
Eye irrigation
Izpiranje oči
Laboratory: sealable for fumigation
Laboratorij: mogoče ga je zatesniti za zaplinjevanje
Surfaces resistant to water, acids, alkalis, solvents, disinfectants, decontamination agents and easy to clean
Površine so odporne proti vodi, kislinam, lugu, topilom, razkužilom in sredstvom za dekontaminacijo ter se enostavno čistijo
Yes (bench)
da (delovna miza)
Yes (bench, floor)
da (delovna miza, tla)
Entry to lab via airlock
Vhod v laboratorij prek zračne zapore
Negative pressure relative to the pressure of the immediate environment
Podtlak glede na tlak neposredne okolice
Extract and input air from laboratory must be HEPA-filtered
Izhodni in vhodni zrak iz laboratorija mora biti filtriran skozi filter HEPA
yes (extract air)
da (izhodni zrak)
Autoclave
Avtoklav
on site
na mestu
in the building
v stavbi
in lab, double ended
v laboratoriju, z vhodno in izhodno odprtino
Protective clothing
Varovalna obleka
Suitable protective clothing
primerna varovalna obleka
Suitable protective clothing (optional footwear)
primerna varovalna obleka (neobvezno čevlji)
Complete change of clothing
popolna menjava obleke
Gloves
Rokavice
Efficient vector control (e.g. for rodents and insects)
Učinkovit nadzor vektorja (npr. za glodalce in mrčes)
Safe Storage of a biological agent
Varno shranjevanje biološkega dejavnika
Laboratory to contain its own equipment
Laboratoriji imajo lastno opremo
Recom-mended
priporočljivo
There are additional European Norms which deal with the management and organisation of laboratories.
Obstajajo dodatne evropske norme, ki obravnavajo upravljanje in organizacijo laboratorijev.
There are other national and international regulations and recommendations which must be followed.
Upoštevati je treba tudi druge nacionalne in mednarodne predpise in priporočila.
The WHO has published its Laboratory Biosafety Manual 3rd Edition on its website:
WHO je na svoji spletni strani objavila svoj priročnik Laboratory Biosafety Manual (3. izdaja):
Containment relating to animal health
Zadrževanje v zvezi z zdravjem živali
Regulations concerning the containment of AI viruses especially HPAI, but also including all AI viruses of H5 and H7 subtypes must be put in place by the veterinary authorities in Member States.
Veterinarski organi držav članic morajo oblikovati predpise v zvezi z zadrževanjem virusov aviarne influence, zlasti HPAI, vendar tudi vseh virusov aviarne influence podtipov H5 in H7.
Some guidance is provided by the World Organisation for Animal Health (OIE) in Chapter 1.4.5 of the Terrestrial Animal Health Code 2005 and HPNAI is regarded as an OIE Containment Group 4 pathogen.
Nekaj navodil zagotavlja Svetovna organizacija za zdravje živali (OIE) v poglavju 1.4.5 Kodeksa o zdravstvenem varstvu kopenskih živali 2005 in HPAI je obravnavana kot patogen 4. skupine zadrževanja OIE.
Although the regulations governing the handling of AI viruses will be put in place by the veterinary authorities of the Member State.
Veterinarski organi držav članic bodo oblikovali predpise, ki urejajo ravnanje z virusi aviarne influence.
The Minimum Safety Requirements applied by the Community reference laboratory, which are the national rules of the United Kingdom, can be viewed on the following website:
Minimalne varnostne zahteve, ki jih uporablja referenčni laboratorij Skupnosti in so nacionalni predpisi Združenega kraljestva, so na voljo na naslednji spletni strani:
Containment relating to human health
Zadrževanje v zvezi z zdravjem ljudi
Laboratories working with AI viruses must be aware at all times that these are at least potential human pathogens and conduct the running of the laboratory to avoid infecting those working in the laboratory and any escape of virus to those outside.
Laboratoriji, ki delajo z virusi aviarne influence, se morajo vedno zavedati, da so to vsaj možni človeški patogeni, in delovanje laboratorija organizirati tako, da se izognejo okužbi ljudi, ki delajo v laboratoriju, in kakršnemu koli uhajanju virusa iz laboratorija.
Guidelines for handling specimens suspected of containing AI A virus can be found on the website of the World Health Organization (WHO):
Navodila za ravnanje z vzorci, za katere obstaja sum prisotnosti virusa aviarne influence A, so na voljo na strani Svetovne zdravstvene organizacije (WHO):
For these full sampling should be carried out and samples stored for later evaluation.
Za to je treba v celoti izvesti vzorčenje in vzorce shraniti za poznejšo oceno.
Wild birds, especially migratory waterfowl, play a very important role as the influenza A virus reservoir, as shown by the isolation of nearly all possible combinations of HA and NA subtypes from wild birds.
Divje ptice, zlasti vodne ptice selivke, so pomemben rezervoar virusa influence A, kar dokazuje izolacija skoraj vseh možnih kombinacij podtipov HA in NA pri divjih pticah.
Generally, except when there has been spill-over of HPAI from infected poultry, only LPAI viruses are detected in wild birds.
Na splošno se pri divjih pticah odkrijejo le virusi LPAI, razen v primeru prenosa HPAI z okužene perutnine.
At one extreme, the clinical signs of the disease seen may be inapparent or slight, producing only mild respiratory signs or egg production problems in laying birds.
Na eni strani so lahko opaženi klinični znaki bolezni neočitni ali šibki in kažejo se le blage dihalne težave ali težave z nesenjem jajc pri nesnicah.
At the other extreme, infections with LPAI viruses may be associated with severe clinical signs of the disease, especially in turkeys, usually with rales, coughing, swelling of the infraorbital sinuses and a febrile condition associated with loss of appetite and with high mortality.
Na drugi strani lahko okužbe z virusi LPAI povzročajo resne klinične znake bolezni, zlasti pri puranih, običajno v obliki hropenja, kašlja, zatekanja infraorbitalnih sinusov in vročinskega stanja skupaj z izgubo apetita in visoko stopnjo umrljivosti.
Incubate at 4 oC overnight.
Inkubirajte čez noč pri 4 °C.
Alternatively, if it is essential to use samples same day, incubate at 37 oC for one hour and centrifuge at 300 x g for five minutes.
Če je vzorce nujno uporabiti še isti dan, se lahko kot nadomestna možnost eno uro inkubirajo pri 37 °C in pet minut centrifugirajo pri 300 x g.
en suite
pri laboratoriju
Birds are examined at 24-hour intervals for 10 days. At each observation, each bird is scored 0 if normal, 1 if sick, 2 if severely sick, 3 if dead.
Ptice se preverjajo 10 dni na vsakih 24 ur. Ob vsakem opazovanju se ptica oceni z 0, če je njeno stanje običajno, 1, če je obolela, 2, če je resno obolela, in 3, če je mrtva.
E-mail: i.h.brown@vla.defra.gsi.gov.uk
Elektronski naslov: i.h.brown@vla.defra.gsi.gov.uk
of 27 June 2006
z dne 27. junija 2006
amending Decision 2006/148/EC on introducing preventive vaccination against highly pathogenic avian influenza H5N1 and related provisions for movements in France
o spremembi Odločbe 2006/148/ES o uvedbi preventivnega cepljenja proti visoko patogeni aviarni influenci H5N1 in s tem povezanih določb o premikih v Franciji
(notified under document number C(2006) 2875)
(notificirano pod dokumentarno številko C(2006) 2875)
Having regard to Council Directive 2005/94/EC of 20 December 2005 on Community measures for the control of avian influenza and repealing Directive 92/40/EEC [1], and in particular Article 57(2) thereof,
ob upoštevanju Direktive Sveta 2005/94/ES z dne 20. decembra 2005 o ukrepih Skupnosti za obvladovanje aviarne influence in razveljavitvi Direktive 92/40/EGS [1], in zlasti člena 57(2) Direktive,
By Commission Decision 2006/148/EC of 24 February 2006 on introducing preventive vaccination against highly pathogenic avian influenza H5N1 and related provisions for movements in France [2], the plan for preventive vaccination against highly pathogenic avian influenza H5N1, submitted by France to the Commission on 21 February 2006 (the preventive vaccination plan), has been approved and certain measures to be applied in France have been laid down where preventive vaccination is carried out.
Z Odločbo Komisije 2006/148/ES z dne 24. februarja 2006 o uvedbi preventivnega cepljenja proti visoko patogeni aviarni influenci H5N1 in s tem povezanih določb o premikih v Franciji [2], je bil načrt preventivnega cepljenja proti visoko patogeni aviarni influenci H5N1, ki ga je Francija predložila Komisiji 21. februarja 2006 („načrt preventivnega cepljenja“) odobren in določeni so bili posebni ukrepi, ki jih je treba uporabljati v Franciji, kjer se preventivno cepljenje izvaja.
According to the preventive vaccination plan, France has undertaken the vaccination of ducks and geese against highly pathogenic avian influenza H5N1, which is considered as a pilot project since there is limited experience with preventive vaccination in these species.
V skladu z načrtom preventivnega cepljenja je Francija izvedla cepljenje rac in gosi proti visoko patogeni aviarni influenci H5N1, ki se zaradi malo izkušenj v zvezi s preventivnim cepljenjem teh vrst šteje za pilotni projekt.
According to the preventive vaccination plan, such as approved by Decision 2006/148/EC, vaccination had to be completed by 1 April 2006.
V skladu z načrtom preventivnega cepljenja, kakor je bil odobren z Odločbo 2006/148/ES, je treba cepljenje zaključiti do 1. aprila 2006.
On 20 April 2006 France presented its first comprehensive report on the use of vaccination.
Francija je 20. aprila 2006 predložila svoje prvo obsežno poročilo o uporabi cepiva.
Furthermore, France has requested a prolongation of the use of preventive vaccination under the same conditions until 30 June 2006 in order to gain further experience and epidemiological insight and has correspondigly submitted an amendment to the preventive vaccination plan.
Poleg tega je Francija vložila zahtevek za podaljšanje preventivnega cepljenja pod istimi pogoji do 30. junija 2006, da bi lahko pridobila več izkušenj in podatkov o epidemiji, zaradi česar je predložila zahtevek za spremembo načrta preventivnega cepljenja.
On the basis of the information contained in the report presented by France, the Commission is of the view that further field experience is needed with respect to the use of vaccination against the spread of highly pathogenic avian influenza H5N1 in ducks and geese.
Na podlagi podatkov iz poročila, ki ga je predložila Francija, Komisija meni, da so v zvezi z uporabo cepiva proti prenosu visoko patogene aviarne influence H5N1 na race in gosi potrebne dodatne praktične izkušnje.
Therefore it is appropriate to approve the prolongation of preventive vaccination submitted by France until 30 June 2006.
Zato je primerno, da se zahtevek, ki ga je predložila Francija za podaljšanje preventivnega cepljenja do 30. junija 2006, odobri.
The first subparagraph of Article 2(1) of Decision 2006/148/EC shall be replaced by the following:
Prvi pododstavek člena 2(1) Odločbe 2006/148/ES se nadomesti z naslednjim:
The plan for preventive vaccination, providing for vaccination until 30 June 2006, against highly pathogenic avian influenza H5N1, submitted by France to the Commission on 21 February 2006, and its amendment of 20 April 2006, is approved (the preventive vaccination plan).’
Načrt preventivnega cepljenja, ki ga je Francija predložila Komisiji 21. februarja 2006, spremembe načrta pa 20. aprila 2006, in predvideva cepljenje proti visoko patogeni aviarni influenci H5N1 do 30. junija 2006, se odobri (‚načrt preventivnega cepljenja‘)“.
Done at Brussels, 27 June 2006.
V Bruslju, 27. junija 2006
OJ L 55, 25.2.2006, p. 51.
UL L 55, 25.2.2006, str. 51.
amending Annex 12 to the Common Consular Instructions and Annex 14a to the Common Manual on the fees to be charged corresponding to the administrative costs of processing visa applications
o spremembi Priloge 12 Skupnih konzularnih navodil in Priloge 14a Skupnega priročnika glede taks, ki ustrezajo upravnim stroškom obravnave prošenj za vizume
Having regard to Council Regulation (EC) No 789/2001 of 24 April 2001 reserving the Council implementing powers with regard to certain detailed provisions and practical procedures for examining visa applications [1],
ob upoštevanju Uredbe Sveta (ES) št. 789/2001 z dne 24. aprila 2001, s katero se Svetu pridržijo izvedbena pooblastila v zvezi z nekaterimi podrobnejšimi predpisi in praktičnimi postopki preverjanja prošenj za vizume [1],
Having regard to Council Regulation (EC) No 790/2001 of 24 April 2001 reserving the Council implementing powers with regard to certain detailed provisions and practical procedures for carrying out border checks and surveillance [2],
ob upoštevanju Uredbe Sveta (ES) št. 790/2001 z dne 24. aprila 2001, s katero se Svetu pridržijo izvedbena pooblastila v zvezi z nekaterimi podrobnejšimi predpisi in praktičnimi postopki izvajanja mejnih kontrol in nadzora [2],
Council Decision 2002/44/EC of 20 December 2001 amending Part VII and Annex 12 to the Common Consular Instructions and Annex 14a to the Common Manual [3] established that the fees to be levied in connection with an application for a visa correspond to the administrative costs incurred.
Odločba Sveta 2002/44/ES z dne 20. decembra 2001 o spremembah Dela VII in Priloge 12 k Skupnim konzularnim navodilom in Priloge 14a k Skupnemu priročniku [3] določa, da takse, ki se obračunajo v zvezi s prošnjo za vizum, ustrezajo nastalim upravnim stroškom.
The Common Consular Instructions and the Common Manual should therefore be amended accordingly.
Zato bi bilo treba ustrezno spremeniti Skupna konzularna navodila in Skupni priročnik.
Council Decision 2003/454/EC of 13 June 2003 amending Annex 12 to the Common Consular Instructions and Annex 14a to the Common Manual on visa fees [4] fixed the amount to be charged corresponding to the administrative costs of processing visa applications at EUR 35.
Sklep Sveta 2003/454/ES z dne 13. junija 2003 določa o spremembi Priloge 12 Skupnih konzularnih navodil in Priloge 14a Skupnega priročnika o vizumskih taksah [4], da je znesek, ki se zaračuna in ki ustreza upravnim stroškom obravnave prošnje za vizum, 35 EUR.
Recital 2 of Decision 2003/454/EC established that the amount to be charged should be revised at regular intervals.
Uvodna izjava 2 Sklepa 2003/454/ES predvideva, da bi bilo treba znesek, ki se zaračunava, revidirati v rednih presledkih.
The amount of EUR 35 no longer covers current visa application processing costs.
Znesek 35 EUR ne zadostuje več za kritje trenutnih stroškov obravnave prošnje za vizum.
Moreover, the consequences of the introduction of the European Visa Information System (VIS) and the biometrics required to introduce the VIS in the visa application examining process should be taken into account.
Poleg tega je treba upoštevati posledice uvedbe evropskega Vizumskega informacijskega sistema (VIS) in biometrije, ki se zahteva za vključitev VIS v postopek preverjanja prošenj za vizum.
The current amount of EUR 35 should be readjusted accordingly in order to cover the additional costs of processing the visa application corresponding to the introduction of biometrics and the VIS.
Trenutni znesek 35 EUR bi bilo torej treba prilagoditi, da bi se pokrili dodatni stroški obravnave prošenj za vizume, ki ustrezajo vključitvi biometrije in VIS.
Regulation (EC) No …/2006 of the European Parliament and of the Council laying down rules on local border traffic at the external land borders of the Member States and amending the provisions of the Schengen Convention [5] allows for the local border traffic permit to be issued free of charge.
Uredba (ES) št. …/2006 Evropskega parlamenta in Sveta o pravilih za obmejni promet na zunanjih kopenskih mejah držav članic ter spremembi določb Schengenske konvencije [5] dovoljuje, da se dovoljenje za obmejni promet izda brezplačno.
Recommendation 2005/761/EC of the European Parliament and of the Council of 28 September 2005 to facilitate the issue by the Member States of uniform short-stay visas for researchers from third countries travelling within the Community for the purpose of carrying out scientific research [6] encourages the issue of visas without administrative fees for researchers.
Priporočilo 2005/761/ES Evropskega parlamenta in Sveta z dne 28. septembra 2005 za olajšanje izdaje enotnih vizumov, ki jih države članice izdajajo za kratkoročno bivanje raziskovalcem iz tretjih držav, ki potujejo znotraj Skupnosti z namenom izvajanja znanstvenih raziskav [6], spodbuja izdajo vizumov brez upravnih taks za raziskovalce.
Waiving or reducing the fees to be charged for nationals of certain third countries in addition to the exceptions mentioned in Article 2 of this Decision may be the subject of agreements between the European Community and the third countries concerned consistent with the Community's overall approach to visa facilitation agreements.
Opustitev ali znižanje taks za vizume za državljane nekaterih tretjih držav poleg izjem iz člena 2 te odločbe je lahko predmet sporazumov med Evropsko skupnostjo in zadevnimi tretjimi državami v skladu s splošnim pristopom Skupnosti k sporazumom o poenostavitvi vizumskih postopkov.
Member States should make maximum use of the possibilities offered by the Schengen acquis for the purpose of developing people-to-people contact with the neighbouring countries consistent with overall EU policy objectives.
Države članice bi morale kar najbolje izkoristiti možnosti, ki jih ponuja schengenski pravni red za razvijanje medosebnih stikov s sosednjimi državami v skladu s splošnimi cilji politik EU.
In accordance with Articles 1 and 2 of the Protocol on the position of Denmark annexed to the Treaty on European Union and to the Treaty establishing the European Community, Denmark is not taking part in the adoption of this Decision, and is not bound by it or subject to its application.
V skladu s členoma 1 in 2 Protokola o stališču Danske, ki je priložen Pogodbi o Evropski uniji in k Pogodbi o ustanovitvi Evropske skupnosti, Danska ne sodeluje pri sprejetju te odločbe, ki zanjo ne velja, niti ni zavezana k njeni uporabi.
Given that this Decision builds upon the Schengen acquis under the provisions of Title IV of Part Three of the Treaty establishing the European Community, Denmark shall, in accordance with Article 5 of the said Protocol, decide within a period of six months after the Council has adopted this Decision whether it will implement it in its national law.
Glede na to, da ta odločba nadgrajuje schengenski pravni red v skladu z določbami naslova IV tretjega dela Pogodbe o ustanovitvi Evropske skupnosti, Danska v skladu s členom 5 navedenega protokola v roku šestih mesecev po sprejetju te odločbe s strani Sveta odloči, ali jo bo izvedla v svojem nacionalnem pravu.